{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:49:19Z","timestamp":1785199759785,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-5159-y","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T08:49:13Z","timestamp":1544431753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Which nasopharyngeal cancer patients need adaptive radiotherapy?"],"prefix":"10.1186","volume":"18","author":[{"given":"Yu-Chang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Wang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chih","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Chun","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hui","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9721-6921","authenticated-orcid":false,"given":"Wen-Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"key":"5159_CR1","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","volume":"33","author":"AW Lee","year":"2015","unstructured":"Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015;33:3356\u201364.","journal-title":"J Clin Oncol"},{"key":"5159_CR2","unstructured":"Health Promotion Administration, Ministry of Health and Welfare. Cancer Registry Annual Report, 2013, Taiwan Taiwan; 2016."},{"issue":"Suppl 1","key":"5159_CR3","doi-asserted-by":"publisher","first-page":"E2130","DOI":"10.1002\/hed.23977","volume":"38","author":"J Co","year":"2016","unstructured":"Co J, Mejia MB, Dizon JM. Evidence on effectiveness of intensity-modulated radiotherapy versus 2-dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: meta-analysis and a systematic review of the literature. Head Neck. 2016;38(Suppl 1):E2130\u201342.","journal-title":"Head Neck."},{"key":"5159_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/00130404-200611000-00009","volume":"12","author":"WS Liu","year":"2006","unstructured":"Liu WS, Kuo HC, Lin JC, et al. Assessment of salivary function change in nasopharyngeal carcinoma treated by parotid-sparing radiotherapy. Cancer J. 2006;12:494\u2013500.","journal-title":"Cancer J"},{"key":"5159_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","volume":"66","author":"EH Pow","year":"2006","unstructured":"Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006;66:981\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5159_CR6","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","volume":"25","author":"MK Kam","year":"2007","unstructured":"Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25:4873\u20139.","journal-title":"J Clin Oncol"},{"key":"5159_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","volume":"104","author":"G Peng","year":"2012","unstructured":"Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012;104:286\u201393.","journal-title":"Radiother Oncol"},{"key":"5159_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/ijc.1004","volume":"96","author":"JC Cheng","year":"2001","unstructured":"Cheng JC, Chao KS, Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer. 2001;96:126\u201331.","journal-title":"Int J Cancer"},{"key":"5159_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/1748-717X-8-277","volume":"8","author":"X Jin","year":"2013","unstructured":"Jin X, Han C, Zhou Y, et al. A modified VMAT adaptive radiotherapy for nasopharyngeal cancer patients based on CT-CT image fusion. Radiat Oncol. 2013;8:277.","journal-title":"Radiat Oncol"},{"key":"5159_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.ijrobp.2011.08.001","volume":"83","author":"Z Zumsteg","year":"2012","unstructured":"Zumsteg Z, DeMarco J, Lee SP, et al. Image guidance during head-and-neck cancer radiation therapy: analysis of alignment trends with in-room cone-beam computed tomography scans. Int J of Radiat Oncol Biol Phys. 2012;83:712\u20139.","journal-title":"Int J of Radiat Oncol Biol Phys"},{"key":"5159_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.radonc.2010.10.009","volume":"98","author":"L Zhao","year":"2011","unstructured":"Zhao L, Wan Q, Zhou Y, et al. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiother Oncol. 2011;98:23\u20137.","journal-title":"Radiother Oncol"},{"key":"5159_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4143\/crt.2015.081","volume":"48","author":"H Lee","year":"2016","unstructured":"Lee H, Ahn YC, Oh D, et al. Tumor volume reduction rate during adaptive radiation therapy as a prognosticator for nasopharyngeal cancer. Cancer Res Treat. 2016;48:537\u201345.","journal-title":"Cancer Res Treat"},{"key":"5159_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijrobp.2005.07.957","volume":"64","author":"EK Hansen","year":"2006","unstructured":"Hansen EK, Bucci MK, Quivey JM, et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J of Radiat Oncol Biol Phys. 2006;64:355\u201362.","journal-title":"Int J of Radiat Oncol Biol Phys"},{"key":"5159_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.ijrobp.2009.04.047","volume":"75","author":"Q Wu","year":"2009","unstructured":"Wu Q, Chi Y, Chen PY, et al. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J of Radiat Oncol Biol Phys. 2009;75:924\u201332.","journal-title":"Int J of Radiat Oncol Biol Phys"},{"key":"5159_CR15","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.ijrobp.2009.04.005","volume":"76","author":"SA Bhide","year":"2010","unstructured":"Bhide SA, Davies M, Burke K, et al. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J of Radiat Oncol Biol Phys. 2010;76:1360\u20138.","journal-title":"Int J of Radiat Oncol Biol Phys"},{"key":"5159_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ijrobp.2009.08.036","volume":"77","author":"W Wang","year":"2010","unstructured":"Wang W, Yang H, Hu W, et al. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J of Radiat Oncol Biol Phys. 2010;77:617\u201321.","journal-title":"Int J of Radiat Oncol Biol Phys"},{"key":"5159_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12094-016-1551-8","volume":"19","author":"Y Luo","year":"2017","unstructured":"Luo Y, Qin Y, Lang J. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis. Clin Transi Oncol. 2017;19:470\u20136.","journal-title":"Clin Transi Oncol"},{"key":"5159_CR18","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/hed.23477","volume":"36","author":"AM Chen","year":"2014","unstructured":"Chen AM, Daly ME, Cui J, et al. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning. Head Neck. 2014;36:1541\u20136.","journal-title":"Head Neck"},{"key":"5159_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.radonc.2015.06.025","volume":"116","author":"E Brown","year":"2015","unstructured":"Brown E, Owen R, Harden F, et al. Predicting the need for adaptive radiotherapy in head and neck cancer. Radiother Oncol. 2015;116:57\u201363.","journal-title":"Radiother Oncol"},{"key":"5159_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1533034615572638","volume":"15","author":"M Surucu","year":"2016","unstructured":"Surucu M, Shah KK, Mescioglu I, et al. Decision trees predicting tumor shrinkage for head and neck cancer: implications for adaptive radiotherapy. Technol Cancer Res Treat. 2016;15:139\u201345.","journal-title":"Technol Cancer Res Treat"},{"key":"5159_CR21","unstructured":"Edge SB, Byrd SR, Compton CC, et al. editors. AJCC Cancer staging manual. 7th edition. Springer-Verlag; New York (NY): 2010. p. 143\u2013164."},{"key":"5159_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00066-011-0015-x","volume":"188","author":"N Hodapp","year":"2012","unstructured":"Hodapp N. The ICRU report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol. 2012;188:97\u20139.","journal-title":"Strahlenther Onkol"},{"key":"5159_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.radonc.2012.09.001","volume":"104","author":"R Guo","year":"2012","unstructured":"Guo R, Sun Y, Yu XL, et al. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma? Radiother Oncol. 2012;104:294\u20139.","journal-title":"Radiother Oncol"},{"key":"5159_CR24","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1259\/bjr\/20695672","volume":"85","author":"X Zhang","year":"2012","unstructured":"Zhang X, Li M, Cao J, et al. Dosimetric variations of target volumes and organs at risk in nasopharyngeal carcinoma intensity-modulated radiotherapy. Bri J Radiol. 2012;85:e506\u201313.","journal-title":"Bri J Radiol"},{"key":"5159_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/jrr\/rru119","volume":"56","author":"I Chitapanarux","year":"2015","unstructured":"Chitapanarux I, Chomprasert K, Nobnaop W, et al. A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer. J Radiat Res. 2015;56:529\u201338.","journal-title":"J Radiat Res"},{"key":"5159_CR26","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.2147\/OTT.S53639","volume":"6","author":"W Tan","year":"2013","unstructured":"Tan W, Li Y, Han G, et al. Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. OncoTargets Ther. 2013;6:1719\u201328.","journal-title":"OncoTargets Ther"},{"key":"5159_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.meddos.2013.09.002","volume":"39","author":"C Chen","year":"2014","unstructured":"Chen C, Fei Z, Chen L, et al. Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy? Med Dosim. 2014;39:34\u20137.","journal-title":"Med Dosim"},{"key":"5159_CR28","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.ijrobp.2012.09.033","volume":"85","author":"H Yang","year":"2013","unstructured":"Yang H, Hu W, Wang W, et al. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2013;85:e47\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5159_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0167-8140(02)00140-8","volume":"64","author":"JC Stroom","year":"2002","unstructured":"Stroom JC, Heijmen BJ. Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 report. Radiother Oncol. 2002;64:75\u201383.","journal-title":"Radiother Oncol"},{"key":"5159_CR30","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1016\/S1470-2045(12)70237-1","volume":"13","author":"V Gregoire","year":"2012","unstructured":"Gregoire V, Jeraj R, Lee JA, O'Sullivan B. Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive? Lancet Oncol. 2012;13:e292\u2013300.","journal-title":"Lancet Oncol"},{"key":"5159_CR31","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.7314\/APJCP.2015.16.12.4825","volume":"16","author":"ZG Liang","year":"2015","unstructured":"Liang ZG, Chen ZT, Li L, et al. Progresses and challenges in chemotherapy for loco-regionally advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 2015;16:4825\u201332.","journal-title":"Asian Pac J Cancer Prev"},{"key":"5159_CR32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1003::AID-CNCR1>3.0.CO;2-F","volume":"82","author":"AT Chan","year":"1998","unstructured":"Chan AT, Teo PM, Leung TW, Johnson PJ. The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer. 1998;82:1003\u201312.","journal-title":"Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-5159-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T19:08:54Z","timestamp":1575918534000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-5159-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5159"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-5159-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol for this study was approved by the Institutional Review Board of Kaohsiung Veterans General Hospital (Protocol number 160310\u20132). This research is retrospective dosimetric review and comparison with a phantom plan. Informed consent for individual patients has been waived by our IRB, named Institutional Review Board of Kaohsiung Veterans General Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1234"}}